Miguel Quijada‐Álamo

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

Maribel Forero‐Castro, Cristina Robledo, Rocí­o Benito et al. · British Journal of Cancer · 2017 · 48 citations · Full text

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Cristina Robledo et al. · Journal of Hematology & Oncology · 2017 · 47 citations · Full text

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of <i>BCR/ABL in vitro</i> and in a xenograft model of chronic myeloid leukemia

Ignacio García‐Tuñón, María Hernández‐Sánchez, José Luis Ordóñez et al. · Oncotarget · 2017 · 39 citations · Full text

Apoptosis, Immunology, Cell Death +20

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

Miguel Quijada‐Álamo, María Hernández‐Sánchez, Verónica Alonso-Pérez et al. · Leukemia · 2020 · 35 citations · Full text

Chronic lymphocytic leukemia patients with<scp><i>IGH</i></scp>translocations are characterized by a distinct genetic landscape with prognostic implications

Claudia Pérez‐Carretero, María Hernández‐Sánchez, Teresa González et al. · International Journal of Cancer · 2020 · 34 citations · Full text